[DOI] [PubMed] [Google Scholar] 112.Fine N.H.F., Doig C.L., Elhassan Y.S., Vierra N.C., Marchetti P., Bugliani M., Nano R., Piemonti L., Rutter G.A., Jacobson D.A., et al
Yes, and this is highly recommended
Adults under 65 saw more dramatic risk reductions (between 32% and 56%) compared to seniors, who experienced reductions of 20% to 40%
Results Participants randomized to exercise performed a median 2.65 session/week (116 min/week at 79% of maximum heart rate) with no significant difference between those who received placebo or liraglutide
From baseline, the mean percentage change in body weight was 11.5, 13.9, and 15.3 percent with 4, 9, and 12 mg of retatrutide, respectively, versus 2.6 percent with placebo